Jump to navigation

Home

SCIAD

The Science of Communications
  • What We Do
    • Brand Strategy and Design
    • Digital Marketing
    • PR and Communications
  • Who We Work With
    • Our Clients
    • Sectors
      • Science
      • Technology & Innovation
      • Healthcare & Medicine
      • Life Science & Biotech
  • News
    • Events
  • About Us
    • Our Team
    • Vacancies at SCIAD
  • Contact Us

News

15th November 2022

Domainex expands Executive and Management Teams to support ongoing growth

Press releases
1st November 2022

BRIM Biotechnology receives FDA agreement on Phase 3 clinical trial design for BRM421, BRIM’s lead candidate for Dry Eye Disease, at End of Phase 2 Meeting

Press releases
28th October 2022

New NoriZite™ Nasal Spray launches in the UK

Press releases
21st October 2022

Sciad attends PPMA Total Show

Blog
19th October 2022

Industry, academia, and policy makers set to discuss the future of healthcare at Pharma Integrates 2022

Press releases
18th October 2022

Why low accuracy chemical dosing is money down the drain

Blog
12th October 2022

Maternova Appoints Luna Mehrain, MD, MSc, as Chief Medical Officer

Press releases
11th October 2022

Watson-Marlow introduces KROHNE flowmeter to safeguard accuracy of fluid flow

Press releases
6th October 2022

Amphista Therapeutics partners with Domainex to advance portfolio of drug discovery projects targeting protein degradation

Press releases
22nd September 2022

Debut event showcases newest trends in drug manufacturing and delivery

Press releases

Pages

  • « first
  • ‹ previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • next ›
  • last »

Contact us today to discuss your marketing and communications challenges

Contact us

Contact Us

Get in touch with Sciad

+44 (0)20 3405 7892

info@sciad.com

7-9 Henrietta Street
Covent Garden
London, WC2E 8PS
United Kingdom

 

Twitter Feed

Tweets from the Sciad Team

Copyright © 2016 Sciad Communications Ltd. All rights reserved.

Open Communications Group | Sciad Newswire

Privacy Policy | Terms and Conditions